Composition for forming artificial skin and method of using the same
The cost of electrostatic spraying devices and crosslinking time are solved by using polymers of organopolysiloxanes with carbon-carbon double bonds and Si-H units with carbon-carbon triple bonds and combinations of low viscosity silicones and catalysts. The long problem achieves the effect of rapid cross-linking.
Patent Information
- Application Number
- CN202180019124.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2020-03-17
- Filing Date
- 2021-03-10
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2041-03-10
AI Technical Summary
In the prior art, electrostatic spraying devices are expensive and complex in operation, with a long cross-linking time, making it difficult to shorten the cross-linking time while maintaining excellent coating performance and coating performance.
Using a composition composed of organopolysiloxane, comprising polymer A with carbon-carbon double bonds or carbon-carbon triple bonds and polymer B with Si-H units, combined with low viscosity silicone and crosslinking catalysts , form a 2-liquid system to shorten the crosslinking time.
It is achieved to significantly shorten the crosslinking time while maintaining excellent coating performance and coating performance, and the crosslinking time can reach less than 30 seconds.
Smart Images

Figure CN115243733B_ABST
Abstract
Description
Technical Field
[0001] The present disclosure relates to artificial skin forming compositions and methods of using the same. Background Art
[0002] In recent years, technologies related to artificial skin that can be used for damaged skin and the like have been known.
[0003] Patent document 1 discloses a method for producing a film, which is a method for producing a film containing fibers on the surface of skin or nails, the method comprising the step of directly electrostatically spraying composition A on human skin or nails, wherein composition A contains (a) one or more volatile substances selected from alcohols and ketones, (b) a water-insoluble polymer for fiber formation, and (c) 0.2% to 25% by mass of water, and the mass ratio (b / c) of component (b) to component (c) is 0.4 to 50.
[0004] Patent document 2 discloses a mixture for body repair that is applied to the skin, the mixture comprising (a) a reactive reinforcing component and (b) a cross-linking component, wherein the cross-linking component catalyzes the cross-linking of the reactive reinforcing component in situ, resulting in the formation of a body repair film on the skin, which has the appearance of natural skin when applied to the body.
[0005] Prior art literature
[0006] Patent Literature
[0007] Patent Document 1: Japanese Patent Application Publication No. 2018-177803
[0008] Patent Document 2: Japanese Patent Application No. 2013-536861 Summary of the invention
[0009] Problems to be solved by the invention
[0010] The film described in patent document 1 is a special film containing fibers formed by electrostatic spraying. In order to form the film, a dedicated expensive electrostatic spraying device is required. In addition, in order to form a desired film at a desired position using the electrostatic spraying device, a certain degree of proficiency must be required.
[0011] On the other hand, the film described in Patent Document 2 can be formed by spreading the film on the skin of the body without using an electrostatic spraying device as described in Patent Document 1. However, this film requires a long time to crosslink, and thus shortening the crosslinking time is desired.
[0012] Therefore, the subject of the present disclosure is to provide an artificial skin-forming composition capable of shortening the crosslinking time while maintaining excellent coating performance and film performance.
[0013] Means for solving problems
[0014] <Method 1>
[0015] A composition for forming artificial skin comprising a first agent and a second agent,
[0016] The first agent comprises (a) a polymer A composed of one or more organopolysiloxanes having at least two carbon-carbon double bonds or at least one carbon-carbon triple bond in the molecule, (b) a polymer B composed of one or more organopolysiloxanes having at least two Si-H units in the molecule, and (c) an organosilicon having a viscosity of 1.5 mPa·s or less at 25° C.,
[0017] The second agent includes a catalyst that promotes cross-linking of the polymer A and the polymer B.
[0018] <Method 2>
[0019] The composition according to embodiment 1, wherein the silicone is polydimethylsiloxane having 3 to 5 silicon atoms.
[0020] <Method 3>
[0021] The composition according to embodiment 1 or 2, wherein the polymer A is at least one selected from the group consisting of vinyl-terminated polydimethylsiloxane, vinyl-terminated diphenylsiloxane-dimethylsiloxane copolymer, vinyl-terminated polyphenylmethylsiloxane, vinylphenylmethyl-terminated vinylphenylsiloxane-phenylmethylsiloxane copolymer, vinyl-terminated trifluoropropylmethylsiloxane-dimethylsiloxane copolymer, vinyl-terminated diethylsiloxane-dimethylsiloxane copolymer, vinylmethylsiloxane-dimethylsiloxane copolymer, trimethylsiloxy-terminated vinylmethylsiloxane-dimethylsiloxane copolymer, silanol-terminated vinylmethylsiloxane-dimethylsiloxane copolymer, vinylmethylsiloxane homopolymer, vinyl T-structure polymer, monovinyl-terminated polydimethylsiloxane, vinylmethylsiloxane terpolymer, and vinylmethoxysilane homopolymer.
[0022] <Method 4>
[0023] The composition according to any one of embodiments 1 to 3, wherein the polymer B is at least one selected from hydride-terminated polydimethylsiloxane, hydride-terminated polyphenyl-(dimethylhydrogensiloxy)siloxane, hydride-terminated methylhydrogensiloxane-phenylmethylsiloxane copolymer, trimethylsiloxy-terminated methylhydrogensiloxane-dimethylsiloxane copolymer, polymethylhydrogensiloxane, trimethylsiloxy-terminated polyethylhydrogensiloxane, triethylsiloxane, methylhydrogensiloxane-phenyloctylmethylsiloxane copolymer, and methylhydrogensiloxane-phenyloctylmethylsiloxane terpolymer.
[0024] <Method 5>
[0025] The composition according to any one of aspects 1 to 4, wherein the viscosity of the first agent is 20,000 mPa·s or less.
[0026] <Method 6>
[0027] The composition according to any one of aspects 1 to 5, wherein the first agent contains at least one selected from the group consisting of fibers, pigments, dyes, and fillers.
[0028] <Method 7>
[0029] The composition according to any one of aspects 1 to 6, wherein the second agent does not contain a pigment, a dye, or a filler.
[0030] <Method 8>
[0031] A method of use, which is a method of use of the composition for forming artificial skin according to any one of aspects 1 to 7, wherein:
[0032] After applying the first agent to the body surface to form a first agent layer, applying the second agent on the first agent layer to cross-link the second agent to form artificial skin; or
[0033] After the second agent is applied to the body surface to form a second agent layer, the first agent is applied on the second agent layer and cross-linked to form artificial skin.
[0034] <Method 9>
[0035] According to the method of use of embodiment 8, the cross-linking time is 30 seconds or less.
[0036] Effects of the Invention
[0037] According to the present disclosure, it is possible to provide an artificial skin-forming composition capable of shortening the crosslinking time while maintaining excellent coating performance and film performance. BRIEF DESCRIPTION OF THE DRAWINGS
[0038] [ Figure 1] is a photograph of a state in which the artificial skin forming composition according to one embodiment of the present disclosure containing fibers is applied to the skin.
[0039] [ Figure 2 ] is a graph showing the relationship between the viscosity of silicone oil and the crosslinking time.
[0040] [ Figure 3 ] is a graph showing the weight reduction rate of various oil components as an indicator of volatility. DETAILED DESCRIPTION
[0041] Hereinafter, embodiments of the present disclosure will be described in detail. The present disclosure is not limited to the following embodiments, and various modifications can be made within the scope of the gist of the invention.
[0042] The composition for forming artificial skin disclosed herein comprises a first agent and a second agent, wherein the first agent comprises (a) a polymer A composed of one or more organopolysiloxanes having at least two carbon-carbon double bonds or at least one carbon-carbon triple bond in the molecule, (b) a polymer B composed of one or more organopolysiloxanes having at least two Si-H units in the molecule, and (c) an organosilicon having a viscosity of 1.5 mPa·s or less at 25° C., and the second agent comprises a catalyst for promoting crosslinking of the polymers A and B.
[0043] Although not limited by the theory, the mechanism of action of the artificial skin-forming composition of the present disclosure that can shorten the crosslinking time while maintaining excellent coating performance and film performance is considered to be as follows.
[0044] In the formation of artificial skin, when a one-component composition without a cross-linking reaction is used, for example, if a diluent with a fast volatilization rate is mixed as a diluent, the drying time after skin application becomes shorter, and the formation time of artificial skin can be shortened. However, the composition disclosed in the present invention requires that after the first agent containing polymer A and polymer B is applied to the skin, a second agent containing a cross-linking accelerator is further applied thereto to cross-link polymer A and polymer B. Such a two-component system with drying and cross-linking reaction is very different from a simple one-component system without a cross-linking reaction in terms of compatibility, cross-linking reactivity, etc., and therefore, the technology used in the simple one-component system cannot be directly adopted. For example, isododecane, which is known as an oil component that is easily volatile, cannot contribute to the shortening of the cross-linking time of the composition disclosed in the present invention.
[0045] The inventors of the present application have found that the addition of a relatively low-viscosity silicone-based oil component to the first agent significantly contributes to shortening the crosslinking time of the composition of the present disclosure. Figure 2 A curve diagram showing this tendency is shown in Figure 2For example, the silicone oil having a viscosity of about 1.5 mPa·s and a crosslinking time of about 30 seconds is an oil component that is less volatile than the silicone oil adjacent to the right thereof, and such silicone oil can shorten the crosslinking time of the composition of the present disclosure. That is, it is believed that in the case of the composition of the present disclosure, the viscosity of the oil component, especially the silicone oil, is more conducive to shortening the crosslinking time than the volatility of the oil component.
[0046] It is also believed that such a silicone having a specific viscosity has excellent compatibility with the polymer A and polymer B contained in the first agent, and can mix the polymer A and polymer B well with sufficient balance. Therefore, it is also possible to reduce or prevent the reduction in coating performance associated with the increase in viscosity and the reduction in film performance associated with uneven cross-linking formation.
[0047] Definitions of terms in this disclosure are as follows.
[0048] In the present disclosure, "viscosity" refers to the standard of resistance of a fluid to deformation by either shear stress or tensile stress. The viscosity of the first and second agents in the composition will affect the thickness, ductility, uniformity and / or consistency of the layer formed on the substrate. Viscosity can be expressed as dynamic viscosity (also known as absolute viscosity, representative units are Pa·s, poise, P, cP.) or kinematic viscosity (representative units are cm 2 / s, Stokes, St, cSt. ) are reported, and the kinematic viscosity is obtained by dividing the dynamic viscosity by the density of the measured fluid. The viscosity range of the components disclosed in this specification is generally provided by the supplier of each component in the unit of kinematic viscosity measured using a rheometer or a Cannon-Fenske tube viscometer (e.g., cSt), but the viscosity of the fluid can also be measured using a rheometer (e.g., a linear shear rheometer or a dynamic shear rheometer) or a viscometer (viscometer, for example, also known as a capillary viscometer or a rotational viscometer).
[0049] "Cross-linking" in the present disclosure also includes a concept generally referred to as "curing".
[0050] In the present disclosure, the term "body surface" refers to the skin surface of the body.
[0051] Composition for forming artificial skin
[0052] The artificial skin-forming composition of the present disclosure (sometimes simply referred to as “composition”) can shorten the crosslinking time while maintaining excellent coating performance and film performance.
[0053] In some embodiments, the coating performance of the composition can be evaluated by the viscosity using a B-type viscometer (manufactured by Shibaura System Co., Ltd., Busmeteron). The viscosity of the first and second agents in the composition of the present disclosure measured at 25°C and 60 rpm (rotor No. 3 or No. 4) immediately after preparation can be set to, for example, 100 mPa·s or more, 500 mPa·s or more, 1,000 mPa·s or more, 2,000 mPa·s or more, 5,000 mPa·s or more, 7,500 mPa·s or more, 10,000 mPa·s or more, or 15,000 mPa·s The viscosity of the composition is preferably 20,000 mPa·s or less, 15,000 mPa·s or less, or 10,000 mPa·s or less, and may be set to 1,000,000 mPa·s or less, 750,000 mPa·s or less, 500,000 mPa·s or less, 250,000 mPa·s or less, 200,000 mPa·s or less, 175,000 mPa·s or less, 150,000 mPa·s or less, 125,000 mPa·s or less, 100,000 mPa·s or less, or 80,000 mPa·s or less. In view of smooth coating performance and suppression of liquid running from the skin, the composition preferably has a viscosity of 20,000 mPa·s or less, 15,000 mPa·s or less, or 10,000 mPa·s or less, and preferably has a viscosity of 3,000 mPa·s or more, 5,000 mPa·s or more, or 7,000 mPa·s or more.
[0054] In addition, in some embodiments, from the viewpoint of smooth coating performance and suppression of liquid flowing from the skin, the viscosity of the first and second agents in the composition of the present disclosure measured at 25° C. and 60 rpm (rotor No. 3) after 2 weeks is preferably 50,000 mPa·s or less, 30,000 mPa·s or less, or 15,000 mPa·s or less, and preferably 5,000 mPa·s or more, 7,000 mPa·s or more, or 10,000 mPa·s or more. The silicone compounded in the first agent has excellent compatibility with polymer A and polymer B, so even after 2 weeks, a significant increase in viscosity can be reduced or prevented.
[0055] In some embodiments, the performance of the film of the artificial skin can be evaluated, for example, based on whether the artificial skin is damaged when it is peeled off from the skin. For example, if the damage of the artificial skin after application is less than 15%, less than 10%, or less than 5% of the whole, it can be said that the film performance is excellent. There is no particular restriction on the lower limit of the damage, for example, it can be specified as 0% or more or greater than 0%. In addition, the film performance can also be evaluated based on the tensile strength, elongation at break, etc. described later.
[0056] The crosslinking time of the composition of the present disclosure can be evaluated using the following method.
[0057] After applying the first agent to the aluminum substrate, apply the second agent to the entire surface by mixing with the first agent, and start the timer. At a certain time point in an atmosphere of 30°C, place a 1.5 cm × 4 cm polypropylene sheet on the surface where the second agent was applied, then place a 15 g weight on the polypropylene sheet and wait for 2 seconds. Then, remove the weight, and then remove the polypropylene sheet from the surface where it was applied, and observe whether there is a composition attached to the polypropylene sheet. The time at the time when the polypropylene sheet was applied when no composition was observed was defined as the "crosslinking time".
[0058] In some embodiments, the composition of the present disclosure can achieve a crosslinking time of 30 seconds or less, 25 seconds or less, or 20 seconds or less. There is no particular limitation on the lower limit of the crosslinking time, and it can be set to, for example, 5 seconds or more, 8 seconds or more, or 10 seconds or more.
[0059] 〈First dose〉
[0060] The first agent constituting the composition of the present disclosure includes (a) polymer A, (b) polymer B, and (c) silicone having a viscosity of 1.5 mPa·s or less at 25° C.
[0061] The first agent may be in an anhydrous form, i.e., a form in which polymers A and B are contained in silicone as an oil component, or may be in the form of an oil-in-water or water-in-oil emulsion. However, from the viewpoint of drying properties and cross-linking properties after application of the first agent to the body surface, it is advantageous for the first agent to be in an anhydrous form.
[0062] The anhydrous form generally does not require preservatives against bacteria or mold, and can therefore be stored for a longer period of time than an emulsion with similar ingredients. Here, in the present disclosure, the term "anhydrous" means that the composition does not contain water, and also means that the water content is low, i.e., 10% by mass or less, 5% by mass or less, 2% by mass or less, 1% by mass or less, or 0.1% by mass or less.
[0063] The first agent is applied to the body surface by coating, etc., and therefore, from the viewpoint of coating performance, it is preferred to have a glass transition temperature below body temperature. For example, the glass transition temperature can be set to below 37°C, below 25°C, below 10°C, or below 0°C. There is no particular restriction on the lower limit of the glass transition temperature, and for example, it can be set to above -30°C, above -20°C, or above -10°C. Here, the so-called "glass transition temperature" refers to the temperature at which a transition from a solid state to a liquid state occurs, and for example, it can be measured using a differential scanning calorimeter (DSC) in accordance with ASTM D3418-03.
[0064] ((a) Polymer A)
[0065] The polymer A is composed of one or more organopolysiloxanes having at least two carbon-carbon double bonds or at least one carbon-carbon triple bond in the molecule, preferably one or more organopolysiloxanes having at least two alkenyl functional groups on average and having a viscosity of 10,000 to 2,000,000 cSt at 25° C. Here, in the present disclosure, “carbon-carbon double bond” and “carbon-carbon triple bond” are sometimes simply referred to as “double bond” and “triple bond”.
[0066] Such an organopolysiloxane may contain a double bond or a triple bond in a terminal unit of the polymer, in a non-terminal monomer unit of the polymer, or in a combination thereof. Among them, it is preferred that the double bond or the triple bond is contained in a non-terminal monomer unit of the polymer.
[0067] In certain embodiments, the double bond-containing monomer units in the organopolysiloxane may be separated by an average of 40 monomer units or more, 200 monomer units or more, 400 monomer units or more, 1,000 monomer units or more, or 2,000 monomer units or more.
[0068] In one embodiment, the amount of the double-bond- or triple-bond-containing monomer unit of the organopolysiloxane having a double-bond or triple-bond can be, for example, 0.01% by mass or more or 0.03% by mass or more and 2% by mass or less or 0.6% by mass or less.
[0069] In one embodiment, the vinyl equivalent of the organopolysiloxane having double bonds or triple bonds can be set to, for example, 0.005 or more or 0.01 per kilogram, and can be set to 0.5 or less or 0.25 or less. The approximate molar amount of the double bonds or triple bonds in the organopolysiloxane can be calculated based on the average molecular weight of the organopolysiloxane. Here, the average molecular weight or molecular mass of each component disclosed in this specification is generally provided by the supplier of each component, and is expressed in Dalton (Da) or the equivalent unit of g / mol.
[0070] In one embodiment, polymer A may have a viscosity of 10,000 to 2,000,000 cSt at 25° C. The lower limit of the viscosity is preferably 20,000 cSt or more, 40,000 cSt or more, 60,000 cSt or more, 80,000 cSt or more, or 100,000 cSt or more, and more preferably 125,000 cSt or more or 150,000 cSt or more. The upper limit of the viscosity is preferably 1,000,000 cSt or less, 500,000 cSt or less, 450,000 cSt or less, 400,000 cSt or less, 350,000 cSt or less, 300,000 cSt or less, or 250,000 cSt or less, more preferably 200,000 cSt or less or 180,000 cSt or less, and further preferably 165,000 cSt or less.
[0071] In one embodiment, polymer A may have an average molecular weight of 60,000Da to 500,000Da. As the lower limit of the average molecular weight, it is preferably 72,000Da or more, 84,000Da or more, 96,000Da or more, or 100,000Da or more, and more preferably 140,000Da or more or 150,000Da or more. As the upper limit of the average molecular weight, it is preferably 200,000Da or less, 190,000Da or less, 180,000Da or less, or 170,000Da or less, more preferably 160,000Da or less, and further preferably 155,000Da or less.
[0072] The polymer A is not limited to the following polymers, but for example, at least one selected from vinyl-terminated polydimethylsiloxanes such as vinyl polydimethylsiloxane, vinyl-terminated diphenylsiloxane-dimethylsiloxane copolymers, vinyl-terminated polyphenylmethylsiloxanes, vinylphenylmethyl-terminated vinylphenylsiloxane-phenylmethylsiloxane copolymers, vinyl-terminated trifluoropropylmethylsiloxane-dimethylsiloxane copolymers, vinyl-terminated diethylsiloxane-dimethylsiloxane copolymers, vinylmethylsiloxane-dimethylsiloxane copolymers, trimethylsiloxy-terminated vinylmethylsiloxane-dimethylsiloxane copolymers, silanol-terminated vinylmethylsiloxane-dimethylsiloxane copolymers, vinylmethylsiloxane homopolymers, vinyl T-structure polymers (branched vinyl polymers), monovinyl-terminated polydimethylsiloxanes, vinylmethylsiloxane terpolymers, and vinylmethoxysilane homopolymers can be used. Among them, vinyl-terminated polydimethylsiloxane is preferred, and vinyl polydimethylsiloxane is more preferred.
[0073] The amount of polymer A in the first agent may be appropriately adjusted according to the desired film performance, etc., and is not particularly limited. For example, the amount of polymer A may be set to 5% by mass or more, 10% by mass or more, 20% by mass or more, 30% by mass or more, 35% by mass or more, or 40% by mass or more, and may be set to 90% by mass or less, 80% by mass or less, 70% by mass or less, 60% by mass or less, 50% by mass or less, or 45% by mass or less, relative to the entire first agent.
[0074] ((b) Polymer B)
[0075] The polymer B is composed of one or more organopolysiloxanes having at least two Si-H units in the molecule, preferably one or more organopolysiloxanes having at least two Si-H units on average and having a viscosity of 2 to 100,000 cSt at 25°C.
[0076] In one embodiment, the organopolysiloxane having Si-H units may contain such Si-H units in terminal units of the polymer, in non-terminal monomer units of the polymer, or in a combination thereof, wherein such Si-H units are preferably contained in non-terminal monomer units of the polymer.
[0077] In one embodiment, the Si-H containing monomer units in the organopolysiloxane may be separated by an average of 1 monomer unit or more, 2 monomer units or more, 5 monomer units or more, 10 monomer units or more, 20 monomer units or more, 40 monomer units or more, 200 monomer units or more, 400 monomer units or more, 1,000 monomer units or more, or 2,000 monomer units or more.
[0078] In one embodiment, the amount of the Si—H-containing monomer unit of the organopolysiloxane having a Si—H unit may be set to 0.003 mass % or more or 0.01 mass % or more and 50 mass % or less or 25 mass % or less.
[0079] In one embodiment, the Si-H content of the organopolysiloxane having Si-H units can be set to 0.1 mmol / g or more, 0.5 mmol / g or more, or 1 mmol / g or more, and can be set to 20 mmol / g or less, 10 mmol / g or less, or 5 mmol / g or less. The approximate molar amount of the Si-H units in the organopolysiloxane can be calculated based on the average molecular weight of the organopolysiloxane.
[0080] In one embodiment, polymer B may have a viscosity of 2 to 500,000 cSt at 25°C. As the lower limit of the viscosity, it is preferably 3 cSt or more, 4 cSt or more, or 12 cSt or more, and more preferably 40 cSt or more. As the upper limit of the viscosity, it is preferably 200,000 cSt or less, 100,000 cSt or less, 50,000 cSt or less, 20,000 cSt or less, 10,000 cSt or less, 5,000 cSt or less, 2,000 cSt or less, or 1,000 cSt or less, and more preferably 500 cSt or less. As the viscosity of polymer B, it is particularly preferred to be in the range of 45 to 100 cSt at 25°C.
[0081] In one embodiment, polymer B may have an average molecular weight of 400 to 500,000Da. As the lower limit of the average molecular weight, it is preferably 500Da or more, 800Da or more, 1,200Da or more, or 1,800Da or more, and more preferably 2,000Da or more. As the upper limit of the average molecular weight, it is preferably 250,000Da or less, 140,000Da or less, 100,000Da or less, 72,000Da or less, 62,700Da or less, 49,500Da or less, 36,000Da or less, or 28,000Da or less, and more preferably 17,200Da or less. As the average molecular weight of polymer B, it is particularly preferably in the range of 2,200Da to 6,000Da.
[0082] Although polymer B is not limited to the following polymers, for example, at least one selected from hydride-terminated polydimethylsiloxanes such as hydrogenated polydimethylsiloxane, hydride-terminated polyphenyl-(dimethylhydrogensiloxy)siloxane, hydride-terminated methylhydrogensiloxane-phenylmethylsiloxane copolymer, trimethylsiloxy-terminated methylhydrogensiloxane-dimethylsiloxane copolymer, polymethylhydrogensiloxane, trimethylsiloxy-terminated polyethylhydrogensiloxane, triethylsiloxane, methylhydrogensiloxane-phenyloctylmethylsiloxane copolymer, and methylhydrogensiloxane-phenyloctylmethylsiloxane trimer can be used. Among them, hydride-terminated polydimethylsiloxane is preferred, and hydrogenated polydimethylsiloxane is more preferred.
[0083] The amount of polymer B in the first agent may be appropriately adjusted according to the desired film performance, etc., and is not particularly limited. For example, the amount of polymer B may be set to 1% by mass or more, 3% by mass or more, or 5% by mass or more, and may be set to 75% by mass or less, 60% by mass or less, 50% by mass or less, 40% by mass or less, 30% by mass or less, 20% by mass or less, or 10% by mass or less, relative to the entire first agent.
[0084] ((c) Silicone having a viscosity of 1.5 mPa·s or less at 25°C)
[0085] Silicone (sometimes simply referred to as "silicone") having a viscosity of 1.5 mPa·s or less at 25°C is contained in the first agent as an oil component. The viscosity of the silicone means the viscosity measured at 25°C using a falling ball viscometer (manufactured by Anton Park, AMVn Automatic Micro Viscometer). The viscosity of the silicone can be set to 1.5 mPa·s or less, 1.4 mPa·s or less, 1.3 mPa·s or less, or 1.2 mPa·s or less. There is no particular limitation on the lower limit of the viscosity of the silicone, and for example, it can be set to 0.5 mPa·s or more, 0.7 mPa·s or more, or 1.0 mPa·s or more.
[0086] From the viewpoint of shortening the drying time, etc., the organosilicon is more preferably volatile. The volatility can be evaluated based on the residual rate of organosilicon when 0.2 g of organosilicon is impregnated in filter paper and left for 60 minutes at room temperature of 24°C and humidity of 50%. The residual rate of organosilicon can be set to, for example, 20% or less, 15% or less, or 10% or less, or can be set to 0% or more or greater than 0%.
[0087] The type of silicone is not particularly limited as long as it has the above-mentioned viscosity, and examples thereof include polydimethylsiloxane (sometimes referred to as "dimethyl silicone") having 3 to 5 silicon atoms. Such silicones may be used alone or in combination of two or more.
[0088] The amount of silicone compounded in the first agent is not particularly limited and can be appropriately adjusted according to coating performance, crosslinking time, etc. For example, the amount of silicone compounded can be set to 10% by mass or more, 15% by mass or more, 20% by mass or more, 25% by mass or more, 30% by mass or more, 35% by mass or more, or 40% by mass or more, and can be set to 70% by mass or less, 65% by mass or less, 60% by mass or less, 55% by mass or less, or 50% by mass or less, relative to the entire first agent.
[0089] 〈Second dose〉
[0090] The second agent constituting the composition of the present disclosure contains a catalyst that promotes the cross-linking of the polymer A and the polymer B described above.
[0091] The second agent may be in an anhydrous form, i.e., a form containing a catalyst and any polymer C in an oil component, or may be in the form of an oil-in-water or water-in-oil emulsion. However, from the viewpoint of the coating properties and cross-linking properties of the second agent on the surface on which the first agent is applied, it is advantageous for the second agent to be in the form of an oil-in-water or water-in-oil emulsion.
[0092] The second agent is applied to the application surface of the first agent by coating or the like, and therefore preferably has a glass transition temperature below body temperature from the viewpoint of coating performance. For example, the glass transition temperature may be set to 37°C or below, 25°C or below, 10°C or below, or 0°C or below. There is no particular limitation on the lower limit of the glass transition temperature, and for example, it may be set to -30°C or above, -20°C or above, or -10°C or above.
[0093] (catalyst)
[0094] Such a catalyst is not particularly limited, and may be, for example, any substance that can cause, promote, or initiate a physical crosslinking reaction and / or a chemical crosslinking reaction. The catalyst may or may not undergo a permanent physical and / or chemical change during or at the end of the process.
[0095] Although the catalyst is not limited to the following catalysts, metal catalysts that can initiate and / or promote crosslinking below body temperature can be cited, such as metal catalysts of Group VIII, such as platinum catalysts, rhodium catalysts, palladium catalysts, cobalt catalysts, nickel catalysts, ruthenium catalysts, osmium catalysts, and iridium catalysts, and metal catalysts of Group IVA, such as germanium catalysts and tin catalysts. Among them, platinum catalysts, rhodium catalysts, or tin catalysts are preferred. These catalysts can be used alone or in combination of two or more.
[0096] Examples of the platinum catalyst include a platinum carbonyl cyclovinylmethylsiloxane complex, a platinum divinyltetramethyldisiloxane complex, a platinum cyclovinylmethylsiloxane complex, a platinum octanal / octanol complex, and other Pt(0) catalysts, such as a Karstedt catalyst, a platinum-alcohol complex, a platinum-alkoxide complex, a platinum-ether complex, a platinum-aldehyde complex, a platinum-ketone complex, a platinum-halogen complex, a platinum-sulfur complex, a platinum-nitrogen complex, a platinum-phosphorus complex, a platinum-carbon double bond complex, a platinum-carbon triple bond complex, a platinum-imide complex, a platinum-amide complex, a platinum-ester complex, a platinum-phosphate complex, a platinum-thiol ester complex, a platinum lone pair electron complex, a platinum-aromatic complex, a platinum π-electron complex, and combinations thereof.
[0097] Examples of the rhodium catalyst include tri(dibutyl sulfide)rhodium trichloride and rhodium trichloride hydrate.
[0098] Examples of the tin catalyst include tin(II) octoate, tin(II) neodecanoate, dibutyltin diisooctylmaleate, di-n-butylbis(2,4-pentanedione)tin, di-n-butylbutoxychlorotin, dibutyltin dilaurate, dimethyltin diceneodecanoate, dimethylhydroxy(oleate)tin, and tin(II) oleate.
[0099] Among these catalysts, a platinum catalyst is more preferred, and a platinum divinyltetramethyldisiloxane complex is particularly preferred.
[0100] The amount of the catalyst in the second agent may be appropriately adjusted according to the desired film performance, etc., and is not particularly limited. For example, the amount of the catalyst may be set to 0.001 mass %, 0.005 mass %, or 0.01 mass %, and may be set to 1 mass %, 0.1 mass %, 0.05 mass %, or 0.03 mass % or less relative to the entire second agent.
[0101] (Polymer C)
[0102] The second agent may optionally contain polymer C.
[0103] In one embodiment, the polymer C may have a viscosity of 0.7 cSt to 10,000 cSt at 25° C. The lower limit of the viscosity is preferably 1 cSt or more, 6 cSt or more, 10 cSt or more, 20 cSt or more, 50 cSt or more, or 100 cSt or more, and more preferably 200 cSt or more. The upper limit of the viscosity is preferably 5,000 cSt or less, 4,000 cSt or less, 2,000 cSt or less, or 1,000 cSt or less, more preferably 500 cSt or less, and particularly preferably 250 cSt or less.
[0104] In one embodiment, polymer C may have an average molecular weight of 180 to 65,000 Da. As the lower limit of the average molecular weight, preferably 500 Da or more, 800 Da or more, 1,500 Da or more, 3,000 Da or more, or 6,000 Da or more, more preferably 9,400 Da or more. As the upper limit of the average molecular weight, preferably 50,000 Da or less, 45,000 Da or less, or 30,000 Da or less, more preferably 17,500 Da or less, particularly preferably 10,000 Da or less.
[0105] Preferred examples of the polymer C include one or more organopolysiloxanes having at least one alkenyl functional group on average and having a viscosity of 0.7 to 10,000 cSt at 25°C.
[0106] Specifically, as the polymer C, for example, a vinyl-terminated polydimethylsiloxane, a vinyl-terminated diphenylsiloxane-dimethylsiloxane copolymer such as vinyl polydimethylsiloxane, a vinyl-terminated polyphenylmethylsiloxane, a vinyl phenylmethyl-terminated vinyl phenylsiloxane-phenylmethylsiloxane copolymer, a vinyl-terminated trifluoropropylmethylsiloxane-dimethylsiloxane copolymer, a vinyl-terminated diethylsiloxane-dimethylsiloxane copolymer, a vinyl methylsiloxane-dimethylsiloxane copolymer, a trimethylsiloxy-terminated vinyl methylsiloxane-dimethylsiloxane copolymer, a silanol-terminated vinyl methyl At least one of siloxane-dimethylsiloxane copolymer, vinyl-terminated vinyl rubber, vinyl methylsiloxane homopolymer, vinyl T-structure polymer, vinyl Q-structure polymer, unsaturated organic polymer (for example, unsaturated fatty alcohol, unsaturated fatty acid, unsaturated fatty ester, unsaturated fatty amide, unsaturated fatty carbamate, unsaturated fatty urea, ceramide, crocetin, lecithin, and sphingosine), monovinyl-terminated polydimethylsiloxane, vinyl methylsiloxane trimer, vinyl methoxysilane homopolymer, vinyl-terminated polyalkylsiloxane polymer, and vinyl-terminated polyalkoxysiloxane polymer. Among them, vinyl-terminated polydimethylsiloxane is preferred, and vinyl polydimethylsiloxane is more preferred.
[0107] The amount of polymer C in the second agent may be appropriately adjusted according to the desired film performance, etc., and is not particularly limited. For example, the amount of polymer C may be set to 0.01% by mass or more, 0.1% by mass or more, 0.3% by mass or more, or 0.5% by mass or more, and may be set to 20% by mass or less, 15% by mass or less, or 10% by mass or less, relative to the entire second agent.
[0108] 〈Ratio of functional groups in polymers A to C〉
[0109] In one embodiment, the molar ratio of the Si-H functional group derived from the polymer B to the alkenyl functional group derived from the polymer A is preferably 60:1 to 1:5, and more preferably 45:1 to 15:1.
[0110] In one embodiment, the molar ratio of the Si-H functional group derived from the polymer B to the alkenyl functional group derived from the polymer C is preferably 60:1 to 1:5, and more preferably 45:1 to 15:1.
[0111] In one embodiment, the molar ratio of the alkenyl functional group derived from polymer A to the alkenyl functional group derived from polymer C is preferably 100:1 to 1:100, and more preferably 10:1 to 1:10.
[0112] 〈Optional Ingredients〉
[0113] The composition of the present disclosure may contain one or more optional components in the first agent and / or the second agent.
[0114] The optional components are not particularly limited, and examples thereof include touch modifiers, tack modifiers, ductility promoters, diluents, adhesion modifiers, emulsifiers, emollients, surfactants, thickeners, solvents, film formers, wetting agents, preservatives, fibers, pigments, dyes, fillers, skin permeation promoters, optical modifiers, scattering agents, adsorbents, magnetic materials, gas transport modifiers, liquid transport modifiers, pH adjusters, sensitizing modifiers, and aesthetic modifiers.
[0115] Examples of the emulsifier include alkoxydimethylsiloxane, alkyldimethylsiloxane, aminodimethylsiloxane, sulfodimethylsiloxane, phosphodimethylsiloxane, borodimethylsiloxane, halogenated dimethylsiloxane, fluorodimethylsiloxane, chlorodimethylsiloxane, bromodimethylsiloxane, charged dimethylsiloxane, and combinations thereof.
[0116] As filler, for example, at least one selected from carbon, silver, mica, zinc sulfide, zinc oxide, titanium dioxide, aluminum oxide, clay, chalk, talc, calcite (for example, CaCO ), barium sulfate, zirconium dioxide, polymer beads, silica (for example, pyrogenic silica, silicic acid or anhydrous silica), alumina silica and calcium silicate can be mentioned, and they can be surface treated. Such filler can improve the physical properties (for example, strength) of the film (artificial skin), and in addition, it can also play the role of viscosity modifier. Among them, as filler, preferably surface treated silica, for example, silica treated by surface treatment agents such as hexamethyldisilazane, polydimethylsiloxane, hexadecylsilane or methacrylic silane. In addition, pyrogenic silica is also preferred, for example, pyrogenic silica surface treated by hexamethyldisilazane etc. can also be suitably used.
[0117] In one embodiment, the filler may have a diameter of 50 to 500 m 2 The specific surface area of the filler is preferably 100 to 350 m 2 / g, more preferably 135 to 250 m 2 Here, the specific surface area of the filler can be calculated using the BET method.
[0118] In one embodiment, the filler may have an area equivalent circular particle size of 1 nm to 20 μm. The area equivalent circular particle size of the filler is preferably 2 nm to 1 μm, and more preferably 5 nm to 50 nm. Here, the so-called area equivalent circular particle size of the filler may refer to, for example, the particle size when converted into a circular particle having the same area as the projected area of the filler particles observed by a transmission electron microscope. The area equivalent circular particle size may be specified as an average value of more than 10 particles.
[0119] When a filler is mixed in the first agent, its mixing amount can be set to, for example, 1 mass % or more, 3 mass % or more, or 5 mass % or more, and can be set to 25 mass % or less, 15 mass % or less, or 10 mass % or less, relative to the entire first agent.
[0120] From the viewpoint of reinforcement of artificial skin, the mass ratio of the total amount of polymers A to C to the filler can be set to 100:1 to 1:1, preferably 50:1 to 2:1, more preferably 15:1 to 3:1, further preferably 10:1 to 4:1, and particularly preferably 5:1 to 9:1.
[0121] At least one of the optional components selected from pigments, dyes and fillers is preferably mixed in the first agent. In particular, regarding pigments and dyes, when they are mixed in the second agent, if the second agent is applied to the application surface of the first agent, solidification will occur in the middle, and the pigment or dye is easily localized, so that color unevenness sometimes occurs. From the viewpoint of suppressing color unevenness, it is advantageous to mix the pigment and dye in the first agent. In addition, in the second agent, pigments, dyes and fillers can also be mixed within the range that does not produce color unevenness, but it is advantageous that they are not included in the second agent.
[0122] In one embodiment, the composition of the present disclosure may be further mixed with one or more drugs for the first agent and / or the second agent. Examples of such drugs include cosmetic agents, therapeutic agents, stimuli-responsive agents, and drug delivery agents.
[0123] Suitable cosmetic agents include, for example, moisturizers, ultraviolet absorbers, skin protectants, skin soothing agents, skin whitening agents, skin glossing agents, skin softeners, skin smoothing agents, skin bleaching agents, skin exfoliants, skin tightening agents, cosmetic agents, vitamins, antioxidants, cell signaling agents, cell regulators, cell interaction agents, skin tanning agents, anti-aging agents, anti-wrinkle agents, spot reducers, α-hydroxy acids, β-hydroxy acids, and ceramides.
[0124] Suitable therapeutic agents include, for example, pain relievers, analgesics, antipruritics, anti-acne agents (e.g., β-hydroxy acids, salicylic acid, benzoyl peroxide), anti-inflammatory agents, antihistamines, corticosteroids, NSAIDs (nonsteroidal anti-inflammatory drugs), antiseptics, antibiotics, antibacterial agents, antifungal agents, antiviral agents, antiallergic agents, anti-irritants, insect repellents, phototherapeutic agents, blood coagulants, antitumor drugs, immune system enhancers, immune system suppressants, coal tar, anthralin, fluocinolone acetonide, methotrexate, cyclosporin, pimecrolimus, tacrolimus, azathioprine, fluorouracil, ceramides, counter-irritants, and skin cooling compounds.
[0125] Examples of suitable agents include antioxidants, vitamins, vitamin D3 analogs, retinoids, minerals, mineral oils, petrolatum, fatty acids, plant extracts, polypeptides, antibodies, proteins, sugars, moisturizers, and emollients.
[0126] 《Method of using the composition for forming artificial skin》
[0127] The composition for forming artificial skin of the present disclosure can be used for cosmetic purposes or medical purposes, for example. Here, the method of using the composition for forming artificial skin of the present disclosure does not include a method of performing surgery, treatment or diagnosis on humans.
[0128] Specifically, as a method of using the composition for forming artificial skin of the present disclosure, for example, a method of applying the first agent to the body surface to form a first agent layer, applying the second agent on the first agent layer, and cross-linking the first agent to form artificial skin can be cited; or a method of applying the second agent to the body surface to form a second agent layer, and then applying the first agent on the second agent layer to form artificial skin. From the viewpoint of obtaining a uniform artificial skin with less unevenness, as the method of using, it is preferred that the first agent is applied to the body surface to form a first agent layer, and then the second agent is applied on the first agent layer to form artificial skin. Here, for the first agent and the second agent, the above-mentioned materials can also be used.
[0129] This method can be completed once, or the method can be carried out multiple times on the formed artificial skin.
[0130] In addition, in some embodiments, the method of using the artificial skin-forming composition of the present disclosure can also be used as a cosmetic method. It should be noted that the so-called "cosmetic method" refers to an operation of applying the artificial skin-forming composition of the present disclosure to the body surface to form artificial skin, adjust the state of the body surface to be beautiful, and thus beautify it, or a method of adjusting the state of the body surface to be beautiful, and thus beautify it, which is different from a method of performing surgery, treatment, or diagnosis on humans.
[0131] The method of applying the first agent or the second agent to the body surface or the first agent layer or the second agent layer is not particularly limited, and for example, spreading by fingers, spraying, transfer, etc. may be used.
[0132] In the method of using the composition of the present disclosure, silicone having a viscosity of 1.5 mPa·s or less at 25° C. is contained in the first agent, so that as described above, the crosslinking time can be 30 seconds or less, 25 seconds or less, or 20 seconds or less.
[0133] 〈Application Area〉
[0134] The composition for forming artificial skin disclosed herein can be applied to any part, as long as it is on the surface of the skin in all parts of the body, that is, on the body surface. For example, it can be suitably applied to the skin surface of the face (lips, eyes, nose, cheeks, forehead, etc.), neck, ears, hands, arms, feet, legs, chest, abdomen, back, etc. Here, skin also includes nails formed by changes in the keratin of the epidermis of the skin and solidification.
[0135] Artificial Skin
[0136] <thickness>
[0137] As the thickness of the artificial skin prepared by the artificial skin forming composition of the above-mentioned disclosure, there is no particular restriction, for example, it can be suitably adjusted in view of air permeability, invisibility, compressibility, clogging of skin, etc. As the thickness of the artificial skin, for example, it can be set to more than 0.5 μm, more than 1 μm, more than 10 μm, more than 30 μm, or more than 40 μm. About the upper limit of thickness, there is no particular restriction, for example, it can be set to less than 150 μm, less than 100 μm, less than 90 μm, less than 80 μm, less than 70 μm, less than 60 μm, or less than 50 μm. Here, thickness can be defined as the average value calculated by measuring the thickness of any part of the artificial skin 5 times using a high-precision digital micrometer (MDH-25MB, made by Mitsutoyo Co., Ltd.).
[0138] <performance>
[0139] The artificial skin prepared from the artificial skin-forming composition of the present disclosure can produce excellent results in various properties such as those shown below.
[0140] (Adhesion)
[0141] In some embodiments, the obtained artificial skin can show good adhesion to the body surface. The adhesion can be evaluated by replacing the adhesion of the artificial skin applied to the polypropylene substrate. As the adhesion of the artificial skin on the polypropylene substrate, it is possible to reach more than 2N / m, more than 5N / m, more than 8N / m, more than 10N / m, or more than 15N / m. There is no particular restriction on the upper limit of the adhesion, for example, from the viewpoint of the peelability of the skin, it can be set to less than 200N / m, less than 100N / m, less than 80N / m, less than 50N / m, or less than 30N / m. Here, the adhesion can be measured using an instrometer according to the peeling adhesion test of ASTM C794.
[0142] (Tensile Strength)
[0143] In some embodiments, the obtained artificial skin can exhibit good tensile strength. As the tensile strength of the artificial skin, it can reach 0.05MPa or more, 0.10MPa or more, 0.20MPa or more, or 0.50MPa or more. There is no particular restriction on the upper limit of the tensile strength, for example, it can be set to 5.0MPa or less, 3.0MPa or less, 2.0MPa or less, or 1.0MPa or less. Here, the tensile strength can be measured using an instron device according to the elongation tensile test of ASTM D5083.
[0144] (Elongation at break)
[0145] In some embodiments, the obtained artificial skin can exhibit good elongation at break. The elongation at break of the artificial skin can be 25% or more, 50% or more, 100% or more, 200% or more, or 400% or more. There is no particular limitation on the upper limit of the elongation at break, and for example, it can be set to 1,500% or less, 1,200% or less, 1,000% or less, 800% or less, or 600% or less. Here, the elongation at break can be measured using an instron apparatus in accordance with the elongation tensile test of ASTM D5083.
[0146] (Oxygen permeability)
[0147] In some embodiments, the obtained artificial skin can exhibit good oxygen permeability. As for the oxygen permeability of the artificial skin, in the artificial skin with a thickness of 300 μm, it can reach 5×10 -9 cm 3 / (cm 2 ·s) or more, 5×10 -7 cm 3 / (cm 2 s) or more, or 5×10 -5 cm3 / (cm 2 There is no particular restriction on the upper limit of oxygen permeability, but it can be set to 5 cm 3 / (cm 2 s) or less, 0.5cm 3 / (cm 2 ·s) or less, 5×10 -2 cm 3 / (cm 2 ·s) or less, 5×10 -3 cm 3 / (cm 2 ·s) or less, or 5×10 -4 cm 3 / (cm 2 Here, the oxygen permeability can be measured using a Mocon device in accordance with the oxygen permeability test for plastic films and sheets of ASTM F2622.
[0148] (Water vapor transmission rate)
[0149] In some embodiments, the obtained artificial skin can exhibit good water vapor permeability. As the water vapor permeability of the artificial skin, in an artificial skin with a thickness of 300 μm, it can reach 1×10 -9 cm 3 / (cm 2 ·s) or more, 1×10 -8 cm 3 / (cm 2 ·s) or more, or 1×10 -7 cm 3 / (cm 2 There is no particular restriction on the upper limit of the water vapor transmission rate, but it can be set to 1.5×10 -1 cm 3 / (cm 2 ·s) or less, 1.5×10 -2 cm 3 / (cm 2 ·s) or less, 1×10 - 4 cm 3 / (cm 2 ·s) or less, 1×10 -5 cm 3 / (cm 2 ·s) or less, or 1×10 -6 cm 3 / (cm 2Here, the water vapor transmission rate can be measured using a Mocon device in accordance with the water vapor transmission rate test for plastic films and sheets of ASTM F1249.
[0150] 《Kit comprising a composition for forming artificial skin》
[0151] The composition for forming artificial skin of the present disclosure can be provided in the form of a kit having the first agent and the second agent constituting the composition. In addition to the first agent and the second agent, the kit may also have an arbitrary member for easily applying the first agent etc. to the body surface or further applying makeup.
[0152] As such arbitrary members, for example, instructions for use, brushes, cotton swabs, cutters, scissors, gloss, lipstick, nail polish, foundation, a cleanser for removing artificial skin from the body surface, a mirror, etc. Here, the so-called "instructions for use" may include, in addition to the usual instructions for use attached to the kit in the form of a document, instructions for use printed on a packaging container such as a packaging container for storing the kit or a tube for injecting the first dose, etc.
[0153] In one embodiment, in order to prevent the first agent and the second agent from coming into contact, the kit may be configured such that these agents are packaged in separate containers or blocks and are applied one at a time or mixed together before or during use.
[0154] Example
[0155] The present invention will be described in more detail with reference to the following examples, but the present invention is not limited thereto. It should be noted that, unless otherwise specified, the blending amount is expressed in mass %.
[0156] 《Examples 1 to 4 and Comparative Examples 1 to 7》
[0157] The polymer A, polymer B, oil component, and filler of each formulation shown in Table 1 were mixed uniformly to prepare the first agent. The viscosity of the first agent after 2 weeks and the viscosity of each oil component used in the first agent were evaluated by the method described below, and the results are shown in Table 1. In addition, the residual rate of each oil component used in the first agent, which is an index of volatility, was evaluated by the method described below, and the results are also shown in Table 1.
[0158] According to the composition of Table 2, the components other than the platinum catalyst dispersed in the silicone oil and the potassium hydroxide partially dissolved in the water were mixed uniformly, and after preparing an aqueous phase, the platinum catalyst dispersed in the silicone oil was mixed into the aqueous phase, and an aqueous potassium hydroxide solution was further mixed to neutralize the mixture, preparing a second agent. The crosslinking time of the composition was evaluated by the method described below using the prepared first and second agents. The results are shown in Table 1.
[0159] In addition, the relationship between the viscosity of the silicone oil components in Table 1, i.e., a mixture of dimethyl silicone (polydimethylsiloxane) and trisiloxane, diphenylsiloxyphenyl trimethicone, five types of polydimethylsiloxanes with different viscosities, and octyl polymethicone, and the crosslinking time of the compositions in the Examples and Comparative Examples using these oil components is shown in a graph. Figure 2 .
[0160] In addition, for reference, a graph showing the weight loss rate as an index of volatility of two types of polydimethylsiloxanes having different viscosities, a mixture of dimethicone (polydimethylsiloxane) and trisiloxane, isododecane, isoparaffin, and octyl polydimethylsiloxane is shown in FIG. Figure 3 The weight reduction rate is obtained in the same manner as the evaluation method of the residual rate of oil described later.
[0161] 〈Evaluation Method〉
[0162] (Evaluation of viscosity)
[0163] The viscosity of the first agent was evaluated at 25°C using a B-type viscometer (Busmeter, manufactured by Shibaura System Co., Ltd.) under the conditions of rotor number 3 or 4 and 60 rpm, and the viscosity of the oil component was evaluated at 25°C using a falling ball viscometer (AMVn Automatic Micro Viscometer, manufactured by Anton Park Co., Ltd.).
[0164] (Evaluation of cross-linking time)
[0165] After applying 71 μl of the first agent on an aluminum substrate, 100 μl of the second agent was applied to the entire surface in a manner of mixing with the first agent, and a timer was started. At a certain time point in an atmosphere of 30°C, a 1.5 cm × 4 cm polypropylene sheet was placed on the surface of the second agent, and then a 15 g weight was placed on the polypropylene sheet. After waiting for 2 seconds, the weight was removed, and the polypropylene sheet was removed from the coated surface to observe whether there was a composition attached to the polypropylene sheet. The time at the time when the polypropylene sheet was applied when no composition was observed was taken as the "crosslinking time".
[0166] (Evaluation of the Residual Rate (Volatility) of Oil)
[0167] 0.2 g of each oil shown in Table 1 was dripped onto filter paper placed in an electronic balance, and after being left at room temperature of 24°C and humidity of 50% for 60 minutes, the weight of the oil was measured, and the weight reduction rate (%) of the oil was calculated from the following formula 1. This was introduced into formula 2 to calculate the residual rate (%) of the oil as an indicator of volatility:
[0168] Oil weight reduction rate (%) = (0.2 (g) - oil weight after 60 minutes (g)) × 100 / 0.2 (g) ... Formula 1
[0169] Remaining rate of oil (%) = 100 - weight reduction rate of oil ... Formula 2
[0170]
[0171] Table 2: Formulation of the second dose
[0172]
[0173] 1) Carbopol (trademark) 980 (manufactured by AB Specialty Silicones)
[0174] 2) C1142AF
[0175] <Results>
[0176] If Figure 2 As can be seen from the results, it can be confirmed that when the oil component mixed in the first agent is a silicone-based oil component, the crosslinking time is shortened as the viscosity of the oil component decreases.
[0177] In addition, for example, when comparing Example 2 and Comparative Example 7 in Table 1, although isododecane in Comparative Example 7 has the same viscosity and volatility (residual rate) as the polydimethylsiloxane in Example 2, the crosslinking time is three times longer. As can be seen from this result, it can be confirmed that in the composition containing the first agent containing specific polymers A and B and the second agent containing a catalyst for promoting crosslinking, in order to shorten the crosslinking time, it is not necessary to use an oil component with a high volatility as the oil component mixed in the first agent, but it is important to use a silicone with a specific viscosity.
[0178] 《Examples 5 to 8》
[0179] The dispersibility of the fibers in the system mixed with the fibers and the formability of artificial skin were evaluated.
[0180] Table 3: Formulation of the first dose containing fiber
[0181]
[0182] 1) Andisil (trademark) VS 165,000 (manufactured by AB Specialty Silicones)
[0183] 2) Andisil (trademark) XL-11 (manufactured by AB Specialty Silicones)
[0184] 3) Aerosil (trademark) r812s (manufactured by EVONIC)
[0185] 4) Wacker (trademark) Silicone 1plus (manufactured by Wacker)
[0186] <Results>
[0187] After preparing the first agent containing fibers according to the composition of Table 3, the first agent was applied to the skin, and the second agent was applied thereto in a manner mixed with the first agent. As a result, it was confirmed that good artificial skin could be formed in any of Examples 5 to 8. Here, Figure 1 The lower part of the back of the hand is an artificial skin prepared by using the first agent of Example 7, Figure 1 The upper part of the back of the hand is the artificial skin prepared using the first agent of Example 8. Figure 1 As shown, in any case, the compounded fibers showed good dispersibility in the artificial skin.
[0188] 《Formulation examples for the first and second doses》
[0189] Tables 4 to 8 below list formulation examples of the first and second agents of the artificial skin forming composition of the present disclosure, but the first and second agents of the artificial skin forming composition of the present invention are not limited to these examples.
[0190] Table 4: Example of formulation for the first dose
[0191]
[0192] 1) Andisil (trademark) VS 165,000 (manufactured by AB Specialty Silicones)
[0193] 2) Andisil (trademark) XL-11 (manufactured by AB Specialty Silicones)
[0194] 3) Aerosil (trademark) r812s (manufactured by EVONIC)
[0195] 4) XIAMETER (trademark) PMX-1184 Silicone Fluid (manufactured by ダウケミカル Co., Ltd.)
[0196] Table 5: Example of formulation for the first dose
[0197]
[0198] 1) Andisil (trademark) VS 165,000 (manufactured by AB Specialty Silicones)
[0199] 2) AndisiI (trademark) XL-11 (manufactured by AB Specialty Silicones)
[0200] 3) KF-6017P (manufactured by Shin-Etsu Chemical Co., Ltd.)
[0201] Table 6: Example of formulation for the second dose
[0202]
[0203] 1) KF-6011P (manufactured by Shin-Etsu Chemical Co., Ltd.)
[0204] 2) Carbopol (trademark) 980 (manufactured by AB Specialty Silicones)
[0205] 3) C1142AF
[0206] 4) SP-500 (Toray Industries, Inc.)
[0207] Table 7: Example of formulation for the second dose
[0208]
[0209] 1) KF-6012 (manufactured by Shin-Etsu Chemical Co., Ltd.)
[0210] 2) Carbopol (trademark) 980 (manufactured by AB Specialty Silicones)
[0211] 3) C1142AF
[0212] 4) Vinizol (trademark) 2140L (manufactured by Daido Chemical Co., Ltd.)
[0213] 5) Pud (Trademark) PuD (manufactured by Aiko Instruments Co., Ltd.)
[0214] 6) ヨドゾール (trademark) GH34F (manufactured by アクゾノーベル Co., Ltd.)
[0215] Table 8: Example of formulation for the second dose
[0216]
[0217] 1) KF-6048 (manufactured by Shin-Etsu Chemical Co., Ltd.)
[0218] 2) KSG-240 (manufactured by Shin-Etsu Chemical Co., Ltd.)
[0219] 3) C1142AF
[0220] 4) KSP-100 (manufactured by Shin-Etsu Chemical Co., Ltd.)
Claims
1. A composition comprising a first agent and a second agent for forming an artificial skin, The first agent comprises (a) a polymer A composed of one or more organopolysiloxanes having at least two carbon-carbon double bonds or at least one carbon-carbon triple bond in the molecule, (b) a polymer B composed of one or more organopolysiloxanes having at least two Si-H units in the molecule, and (c) an organosilicon having a viscosity of 1.5 mPa·s or less at 25° C., The second agent includes a catalyst that promotes cross-linking of the polymer A and the polymer B. The viscosity is measured at 25° C. using a falling ball viscometer.
2. The composition according to claim 1, wherein the organosilicon is polydimethylsiloxane having 3 to 5 silicon atoms.
3. The composition according to claim 1 or 2, wherein the polymer A is at least one selected from the group consisting of vinyl terminated polydimethylsiloxane, vinyl terminated diphenylsiloxane-dimethylsiloxane copolymer, vinyl terminated polyphenylmethylsiloxane, vinyl phenylmethyl terminated vinyl phenylsiloxane-phenylmethylsiloxane copolymer, vinyl terminated trifluoropropylmethylsiloxane-dimethylsiloxane copolymer, vinyl terminated diethylsiloxane-dimethylsiloxane copolymer, vinyl methylsiloxane-dimethylsiloxane copolymer, trimethylsiloxy terminated vinyl methylsiloxane-dimethylsiloxane copolymer, silanol terminated vinyl methylsiloxane-dimethylsiloxane copolymer, vinyl methylsiloxane homopolymer, vinyl T-structure polymer, and vinyl methoxysilane homopolymer.
4. The composition according to claim 1 or 2, wherein the polymer A is at least one selected from monovinyl-terminated polydimethylsiloxane and vinylmethylsiloxane terpolymer.
5. The composition according to claim 1 or 2, wherein the polymer B is at least one selected from hydride-terminated polydimethylsiloxane, hydride-terminated polyphenyl-(dimethylhydrogensiloxy)siloxane, hydride-terminated methylhydrogensiloxane-phenylmethylsiloxane copolymer, trimethylsiloxy-terminated methylhydrogensiloxane-dimethylsiloxane copolymer, polymethylhydrogensiloxane, trimethylsiloxy-terminated polyethylhydrogensiloxane, triethylsiloxane and methylhydrogensiloxane-phenyloctylmethylsiloxane copolymer. The composition according to claim 1 or 2, wherein the polymer B is methyl hydrogen siloxane-phenyl octyl methyl siloxane terpolymer. 7 . The composition according to claim 1 , wherein the viscosity of the first agent is 20,000 mPa·s or less.
8. The composition according to claim 1 or 2, wherein the first agent comprises at least one selected from the group consisting of fibers, pigments, dyes and fillers.
9. The composition according to claim 1 or 2, wherein the second agent does not contain pigments, dyes or fillers.
10. A method of use, which is a method of use of the composition according to any one of claims 1 to 9, and is a method of use for non-diagnostic or therapeutic purposes, wherein: After applying the first agent to the body surface to form a first agent layer, applying the second agent on the first agent layer to cross-link the second agent to form artificial skin; or, After the second agent is applied to the body surface to form a second agent layer, the first agent is applied on the second agent layer and cross-linked to form artificial skin. The method of use according to claim 10 , wherein the cross-linking time is 30 seconds or less.
